CN Patent

CN117561057A — 用raf抑制剂治疗癌症

Assigned to Pierre Fabre Medicament SA · Expires 2024-02-13 · 2y expired

What this patent protects

本文提供了用于治疗癌症的组合物和方法。所述组合物包含RAF抑制剂。一些实施方案包括以RAF抑制剂与至少一种肿瘤学治疗剂为特征的组合疗法。

USPTO Abstract

本文提供了用于治疗癌症的组合物和方法。所述组合物包含RAF抑制剂。一些实施方案包括以RAF抑制剂与至少一种肿瘤学治疗剂为特征的组合疗法。

Drugs covered by this patent

Patent Metadata

Patent number: CN117561057A
Jurisdiction: CN
Classification: —
Expires: 2024-02-13
Drug substance claim: No
Drug product claim: No
Assignee: Pierre Fabre Medicament SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.